Ignite Creation Date:
2024-05-06 @ 8:32 AM
Last Modification Date:
2024-10-26 @ 12:02 PM
Study NCT ID:
NCT02767804
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-09
First Post:
2016-04-30
Brief Title:
eXalt3 Study Comparing X-396 Ensartinib to Crizotinib in ALK Positive Non-Small Cell Lung Cancer NSCLC Patients
Sponsor:
Xcovery Holdings Inc
Organization:
Xcovery Holdings Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-06
Start Date Type:
ACTUAL
Primary Completion Date:
2024-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2016-04-30
First Submit QC Date:
May 9 2016
Study First Post Date:
2016-05-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-19
Last Update Post Date:
2024-05-09
Last Update Post Date Type:
ACTUAL